Register for the 13th Annual Meeting of the North American Section

Presented by the International Academy of Cardiovascular Sciences  

Educational Overview

This conference will highlight the latest advances in cardiovascular medicine, including gene and cell-based therapies, heart failure, atherosclerosis, diabetes, obesity, cardiac imaging, electrophysiology, interventional cardiology, and cardiac surgery. Participants will gain insights into emerging research, innovative diagnostic approaches, and novel therapeutic strategies aimed at improving cardiovascular health and patient outcomes.

Target Audience

This activity is designed for cardiologists, cardiovascular surgeons, internists, endocrinologists, primary care physicians, physician assistants, nurse practitioners, nurses, pharmacists, scientists, researchers, fellows, residents, medical students, and other healthcare professionals interested in cardiovascular health and disease.

Learning Objectives

Upon completion of this activity, participants should be able to:

  1. Describe the current state of gene therapy, regenerative interventions, and reparative cell-based therapies in the management of cardiomyopathy and other cardiovascular diseases.
  2. Assess the impact of metabolic changes, obesity, diet, and environmental factors on cardiovascular disease risk and identify evidence-based prevention strategies.
  3. Discuss the roles of diabetes and inflammation in the pathogenesis of atherosclerosis and evaluate emerging therapies for atherosclerosis and dyslipidemias.
  4. Evaluate novel therapeutic targets for improving outcomes in patients with heart failure with reduced or preserved ejection fraction.
  5. Apply advances in cardiovascular imaging to the diagnosis and management of diverse cardiac conditions.
  6. Summarize recent developments in cardiac electrophysiology, interventional cardiology, and cardiac surgery and their implications for clinical practice.
Accreditation and Credit Information 
ACCME Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the ACCME through the joint providership of the University of Louisville School of Medicine and the International Academy of Cardiovascular Sciences. The University of Louisville School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
 
Credit Designation Statement: The University of Louisville School of Medicine designates this live activity for a maximum of 16.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with their participation.
 
Nursing Continuing Education: Approved by the Kentucky Board of Nursing for 19.2 contact hours through University of Louisville Hospital (Provider #4-0068-12-26-1479). Approval does not imply endorsement. Completion requires full attendance and evaluation.
 
All planners and faculty have disclosed relevant financial relationships. All conflicts have been mitigated.
accme logo
kybnursing
image001 2
oped logo 2023

Registration Fees

September 10-12, 2026

The Galt House

Louisville, Kentucky

Early Bird Registration - $250

Early bird remains open until July 15, 2026

General Registration - $350

General Registration remains open until September 1, 2026

Invited Speakers - $0

On- Site Registration - $450

One-Day Registration - $150

UofL Student/Post-Doc Fellow/Clinical Residents & Fellows - $20

Student/Post-Doc Fellow/Clinical Residents & Fellows (Non-UofL) - $50

Industry - $700

Shopping Cart